Unknown

Dataset Information

0

A dominant negative ADIPOQ mutation in a diabetic family with renal disease, hypoadiponectinemia, and hyperceramidemia.


ABSTRACT: Adiponectin, encoded by ADIPOQ, is an insulin-sensitizing, anti-inflammatory, and renoprotective adipokine that activates receptors with intrinsic ceramidase activity. We identified a family harboring a 10-nucleotide deletion mutation in ADIPOQ that cosegregates with diabetes and end-stage renal disease. This mutation introduces a frameshift in exon 3, resulting in a premature termination codon that disrupts translation of adiponectin's globular domain. Subjects with the mutation had dramatically reduced circulating adiponectin and increased long-chain ceramides levels. Functional studies suggest that the mutated protein acts as a dominant negative through its interaction with non-mutated adiponectin, decreasing circulating adiponectin levels, and correlating with metabolic disease.

SUBMITTER: Simeone CA 

PROVIDER: S-EPMC9307825 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications


Adiponectin, encoded by ADIPOQ, is an insulin-sensitizing, anti-inflammatory, and renoprotective adipokine that activates receptors with intrinsic ceramidase activity. We identified a family harboring a 10-nucleotide deletion mutation in ADIPOQ that cosegregates with diabetes and end-stage renal disease. This mutation introduces a frameshift in exon 3, resulting in a premature termination codon that disrupts translation of adiponectin's globular domain. Subjects with the mutation had dramaticall  ...[more]

Similar Datasets

| S-EPMC10485651 | biostudies-literature
| S-EPMC4456653 | biostudies-literature
| S-EPMC344408 | biostudies-literature
| S-EPMC7598087 | biostudies-literature
| S-EPMC7341419 | biostudies-literature
| S-EPMC10242352 | biostudies-literature
| S-EPMC4919558 | biostudies-literature
| S-EPMC5413770 | biostudies-literature
| S-EPMC10841703 | biostudies-literature
| S-EPMC5244381 | biostudies-literature